Home/Filings/4/0000905148-24-001654
4//SEC Filing

LAPOINTE ANTHONY GREGG 4

Accession 0000905148-24-001654

CIK 0001034842other

Filed

May 28, 8:00 PM ET

Accepted

May 29, 7:20 PM ET

Size

7.0 KB

Accession

0000905148-24-001654

Insider Transaction Report

Form 4
Period: 2024-05-25
Transactions
  • Award

    Common Stock

    2024-05-25+25,000100,000 total
  • Award

    Stock Option (Right to Buy)

    2024-05-25+30,00030,000 total
    Exercise: $0.91Exp: 2034-05-25Common Stock (30,000 underlying)
Footnotes (2)
  • [F1]The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors.
  • [F2]The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors.

Documents

1 file

Issuer

RIGEL PHARMACEUTICALS INC

CIK 0001034842

Entity typeother

Related Parties

1
  • filerCIK 0001331860

Filing Metadata

Form type
4
Filed
May 28, 8:00 PM ET
Accepted
May 29, 7:20 PM ET
Size
7.0 KB